A study from St. Jude Children's Research Hospital uncovered an alternative binding pocket within nuclear receptors, revealing a much-needed new therapy route for this important class of drug targets. The scientists found the "hidden" pocket on the pregnane X receptor (PXR), a protein that drives the unwanted breakdown of chemotherapies.